Oct 07, 2021 XOMA Purchases Commercial Payment Rights to BLA-Review-Stage Asset View Press Release Learn More
Nov 4, 2021 • 7:40 AM EDT XOMA Earns $35 Million Milestone Payment as Anti-TGFβ Antibody Enters Phase 3 Clinical Study in Metastatic Pancreatic Cancer
Nov 4, 2021 • 7:30 AM EDT XOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Events
Sep 22, 2021 • 7:30 AM EDT XOMA to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
